Revelation Biosciences, Inc. (REVB) ownership: Top institutional holder: ARMISTICE CAPITAL, LLC ($387889.00). Insider activity: Net Buyer (7 buys, 6 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 323241.00 | $387889.00 | 2026-03-31 |
| SABBY MANAGEMENT, LLC | 99432.00 | $119318.00 | 2026-03-31 |
| GEODE CAPITAL MANAGEMENT, LLC | 43195.00 | $51833.00 | 2026-03-31 |
| CITADEL ADVISORS LLC | 54728.00 | $43771.00 | 2025-12-31 |
| VANGUARD GROUP INC | 52505.00 | $42004.00 | 2025-12-31 |
| NORTHERN TRUST CORP | 21907.00 | $17521.00 | 2025-12-31 |
| VANGUARD FIDUCIARY TRUST CO | 13127.00 | $15752.00 | 2026-03-31 |
| XTX Topco Ltd | 11385.00 | $13662.00 | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Sell | null | 2026-08-17 | |
| Buy | null | 2026-04-30 | |
| Buy | null | 2026-04-30 |
Back to REVB overview · REVB earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.